Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Advances in Therapy

• Publication date

  2014-08-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12325-014-0148-2PMID 25145549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Locally advanced melanoma

  2020cited by this paper
• Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

  2013cited by this paper
• Nivolumab plus ipilimumab in advanced melanoma.

  2013cited by this paper
• Survival and long-term follow-up of safety and response in patients (pts) with advanced melanoma (MEL) in a phase I trial of nivolumab (anti-PD-1; BMS-936558; ONO-4538).

  2013cited by this paper
• Improved survival with MEK inhibition in BRAF-mutated melanoma.

  2012cited by this paper
• Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.

  2012cited by this paper
• Advantages of preoperative ultrasound in conjunction with lymphoscintigraphy in detecting malignant melanoma metastases in sentinel lymph nodes: a retrospective analysis in 221 patients with malignant melanoma AJCC Stages I and II

  2012cited by this paper
• Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.

  2012cited by this paper
• Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

  2012cited by this paper
• Efficacy and safety of oral MEK162 in patients with locally advanced and unresectable or metastatic cutaneous melanoma harboring BRAFV600 or NRAS mutations.

  2012cited by this paper
• Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

  2012cited by this paper
• Update on immunohistochemistry in melanocytic lesions.

  2012cited by this paper
• Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1697) .

  2011cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.

  2011cited by this paper
• Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes

  2011cited by this paper
• Comparison of the diagnostic accuracy of whole‐body MRI and whole‐body CT in stage III/IV malignant melanoma

  2011cited by this paper
• Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies

  2011cited by this paper
• Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.

  2011cited by this paper
• Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha

  2011cited by this paper
• Reduced melanoma after regular sunscreen use: randomized trial follow-up.

  2011cited by this paper
• Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.

  2011cited by this paper
• Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

  2011cited by this paper
• Revised U.K. guidelines for the management of cutaneous melanoma 2010

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Cancer mortality trends in Spain: 1980-2007.

  2010cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom

  2010cited by this paper
• Cancer survival in Spain: estimate for nine major cancers.

  2010cited by this paper
• The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France.

  2010cited by this paper
• Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

  2010cited by this paper
• Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic?

  2010cited by this paper
• Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters.

  2010cited by this paper
• British Association of Dermatologists Clinical Standards Unit. Revised U.K. guidelines for the management of cutaneous melanoma

  2010cited by this paper
• Melanoma localmente avanzado. Estudio y tratamiento

  2009cited by this paper
• Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma

  2009cited by this paper
• [Experience in the treatment of cutaneous in-transit melanoma metastases and satellitosis with intralesional interleukin-2].

  2009cited by this paper
• Surgical Management of Solitary Metastatic Melanoma

  2009cited by this paper
• Surgery and radiotherapy in the treatment of cutaneous melanoma

  2009cited by this paper
• Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases

  2009cited by this paper
• Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.

  2009cited by this paper
• [Clinical and epidemiologic profile of melanoma patients according to sun exposure of the tumor site].

  2009cited by this paper
• [Study and treatment of locally advanced melanoma].

  2009cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy.

  2009cited by this paper
• Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

  2009cited by this paper
• Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.

  2009cited by this paper
• Experiencia en el tratamiento de satelitosis y metástasis cutáneas en tránsito de melanoma con interleucina 2 intralesional

  2009cited by this paper
• Perfil clínico y epidemiológico de los pacientes con melanoma cutáneo según el grado de exposición solar de la localización del melanoma

  2009cited by this paper
• Biopsy of the pigmented lesion--when and how.

  2008influential reference
• Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma

  2008cited by this paper
• Predicting outcomes in metastatic melanoma.

  2008cited by this paper
• Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

  2008influential reference
• Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis.

  2008cited by this paper
• Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas.

  2007cited by this paper
• Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report.

  2007cited by this paper
• Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.

  2007cited by this paper
• Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.

  2007cited by this paper
• Melanoma: Clinical practice guidelines in oncology™

  2006cited by this paper
• Histologic criteria for diagnosing primary cutaneous malignant melanoma

  2006cited by this paper
• Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.

  2006cited by this paper
• Complete metastasectomy in patients with stage IV metastatic melanoma.

  2006cited by this paper
• Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma.

  2006cited by this paper
• Squamous cell carcinoma: from precursor lesions to high-risk variants

  2006cited by this paper
• Presentation and detection of invasive melanoma in a high-risk population.

  2006cited by this paper
• The role of radiotherapy in the management of malignant melanoma.

  2006cited by this paper
• Radiofrequency ablation in palliative supportive care: early clinical experience.

  2006cited by this paper
• Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.

  2006cited by this paper
• Role of the CDKN2A locus in patients with multiple primary melanomas.

  2005cited by this paper
• [Melanoma epidemiology in Spain].

  2005cited by this paper
• Increased incidence of melanoma in renal transplantation recipients

  2005cited by this paper
• Epidemiología del melanoma en España

  2005cited by this paper
• Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

  2005cited by this paper
• Stereotactic radiosurgery for four or more intracranial metastases.

  2005cited by this paper
• Risk Factors for Melanoma by Body Site

  2005cited by this paper
• Clinical Diagnosis of Actinic Keratosis Identifies an Elderly Population at High Risk of Developing Skin Cancer

  2005cited by this paper
• Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions.

  2005cited by this paper
• Consumption of the Epidermis: A Diagnostic Criterion for the Differential Diagnosis of Melanoma and Spitz Nevus

  2004cited by this paper
• Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.

  2004cited by this paper
• Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.

  2004cited by this paper
• Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

  2004cited by this paper
• Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.

  2004cited by this paper
• Interferon Alpha as Adjuvant Postsurgical Treatment of Melanoma: A Meta-Analysis

  2004cited by this paper
• Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.

  2003cited by this paper
• Successful treatment of in‐transit melanoma metastases using topical 2‐4 dinitrochlorobenzene

  2003cited by this paper
• Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.

  2003cited by this paper
• Clinical and Laboratory Investigations Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts

  2003cited by this paper
• Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions.

  2003cited by this paper
• Clinical practice. Dysplastic nevi.

  2003cited by this paper
• Pattern analysis, not simplified algorithms, is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology

  2003cited by this paper
• Herpes Zoster and Postherpetic Neuralgia,2nd revised and enlarged edition (Pain Research and Clinical Management, vol 11)

  2003cited by this paper
• Diagnostic accuracy of dermoscopy.

  2002cited by this paper
• Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.

  2002cited by this paper
• Thin primary cutaneous melanomas

  2002cited by this paper
• An assessment of factors related to tumor thickness and delay in diagnosis of melanoma in southern Italy.

  2002cited by this paper
• Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients

  2001cited by this paper
• Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001influential reference
• Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.

  2001cited by this paper
• Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas

  2001cited by this paper

• Investigation of the Ability of Crocin to Treat Skin Cancer Chemically Induced in Mice via the Inhibition of the Wnt/β-Catenin and Fibrotic Pathway

  2023cites this paper
• Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression

  2022cites this paper
• Antitumor activity of adiponectin in mice model of skin cancer via modulation of sulfatase-2 and MMP9 activity on HSPGs

  2022cites this paper
• Incidence, mortality and medical costs of patients hospitalized with melanoma in Spain: a retrospective multicentre observational study

  2021cites this paper
• Anti-Cancer Properties of Nicotinic Cid-Alpha Linolenic Acid Derivative on A375 Melanoma Cell Line: Assessment of Apoptosis and WNT Signaling Pathways

  2021cites this paper
• Circular RNAs: new genetic tools in melanoma.

  2020cites this paper
• New insights on the role of autophagy in the pathogenesis and treatment of melanoma

  2020cites this paper
• Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice

  2020cites this paper
• EMG1 interacts with NOP14 to regulate the growth, migration, and invasion of melanoma cells via the Wnt/β-catenin pathway

  2020cites this paper
• Ex Vivo Exposure of Human Melanoma Tissue to Cold Physical Plasma Elicits Apoptosis and Modulates Inflammation

  2020cites this paper
• Trends in mortality from cutaneous malignant melanoma in Spain (1982–2016): sex‐specific age‐cohort‐period effects

  2019cites this paper
• Knockdown of aristaless-like homeobox1 inhibits epithelial-mesenchymal transition through Wnt/β-catenin signaling pathway in melanoma cells.

  2019cites this paper
• Surgery on primary melanoma of the breast

  2019cites this paper
• Disease-Free Survival for Patients with Thin Melanomas according to the American Joint Committee on Cancer 8th Edition

  2019cites this paper
• Blocking Wnt as a therapeutic target in mice model of skin cancer

  2019cites this paper
• Nomogram for predicting the survival of patients with malignant melanoma: A population analysis

  2019cites this paper
• The therapeutic effects of blocking IGF-R1 on mice model of skin cancer

  2019cites this paper
• Is it melanoma-associated retinopathy or drug toxicity? Bilateral cystoid macular edema posing a diagnostic and therapeutic dilemma

  2018cites this paper
• NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway

  2018cites this paper
• Clinicopathological characteristics of cutaneous malignant melanoma in patients at a tertiary hospital in Macaronesia. Survival as a function of locoregional prognostic factors per the American Joint Committee on Cancer

  2018cites this paper
• MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

  2017cites this paper
• Apoptotic Effect of Astragalin in Melanoma Skin Cancers via Activation of Caspases and Inhibition of Sry‐related HMg‐Box Gene 10

  2017cites this paper
• Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.

  2017cites this paper
• Dendritic cell therapy in melanoma.

  2017cites this paper
• Attenuated in vitro effects of IFN‐&agr;, IL‐2 and IL‐12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients

  2017cites this paper
• Affinity Gradient of Chimeric Antigen Receptor T-Cells Against Low-Antigen Density Target

  2017cites this paper
• miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN.

  2017cites this paper
• Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.

  2016cites this paper
• Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

  2016cites this paper
• MicroRNA-125b suppresses the epithelial–mesenchymal transition and cell invasion by targeting ITGA9 in melanoma

  2016cites this paper
• Tumor Markers Currently Utilized in Cancer Care

  2015cites this paper
• Kidney transplant from a monozygotic twin living donor with no maintenance immunosuppression

  2015cites this paper
• Primary malignant melanoma of the breast: case report and review of the literature.

  2015influential citation
• MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma

  2015cites this paper
• Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma

  2015cites this paper
• Kidney transplant from a living monozygotic twin donor with no maintenance immunosuppression.

  2015cites this paper
• Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells

  2015cites this paper
• Ipilimumab-Associated Retinopathy.

  2015cites this paper
• Problems of Differential Diagnosis in Melanoma Arising from Blue Naevus

  2015cites this paper
• Pembrolizumab: Pharmacology and Therapeutics Review

  2014cites this paper